Sign in

CIK 0001764013

  • Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
832771572
Phone
+1 917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$895,852
in 9 filings, $173K under 10b5-1 plans

Net −$895,852. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-02 Venker Eric Chief Executive Officer Sale −3,506 $34.11 $120K 257,075
2026-10-01 Venker Eric Chief Executive Officer Exercise or conversion +92,187 $14.46 $1.3M 346,467
2026-10-01 Venker Eric Chief Executive Officer Returned to the company −85,886 $33.65 $2.9M 260,581
2026-10-01 Venker Eric Chief Executive Officer Exercise or conversion · Capped Value Appreciation Rights −92,187 921,875
2026-07-02 Venker Eric Chief Executive Officer Sale −3,092 $38.48 $119K 254,280
2026-07-01 Venker Eric Chief Executive Officer Exercise or conversion +92,188 $14.46 $1.3M 344,001
2026-07-01 Venker Eric Chief Executive Officer Returned to the company −86,629 $38.14 $3.3M 257,372
2026-07-01 Venker Eric Chief Executive Officer Exercise or conversion · Capped Value Appreciation Rights −92,188 1,014,062
2026-04-07 Venker Eric Chief Executive Officer Grant or award +232,252 251,813
2026-04-07 Venker Eric Chief Executive Officer Grant or award · Stock Option (right to buy) +336,043 336,043
2026-04-02 Venker Eric Chief Executive Officer Sale −12,820 $24.04 $308K 20,970
2026-04-02 Venker Eric Chief Executive Officer Sale −1,409 $24.60 $35K 19,561
2026-04-01 Venker Eric Chief Executive Officer Exercise or conversion +368,750 $14.46 $5.3M 368,750
2026-04-01 Venker Eric Chief Executive Officer Returned to the company −334,960 $25.10 $8.4M 33,790
2026-04-01 Venker Eric Chief Executive Officer Exercise or conversion · Capped Value Appreciation Rights −368,750 1,106,250
2025-07-28 Venker Eric Chief Executive Officer Grant or award · Stock Option (right to buy) +1,300,000 1,300,000
2025-07-28 Venker Eric Chief Executive Officer Grant or award · Stock Option (right to buy) +189,900 189,900
2025-07-28 Venker Eric Chief Executive Officer Grant or award · Capped Value Appreciation Rights +1,475,000 1,475,000

Page 1 of 1 · 18 trades